Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Estee Lauder Companies Inc (EL) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance

Estee Lauder Companies IncTrade
Edwards Lifesciences Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Estee Lauder Companies Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Estee Lauder Companies Inc trades at $93.84 (market cap $34.22B), while Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Estee Lauder Companies Inc pays a 1.48% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

ELEW
Market Cap
$34.22B$49.44B
Volume
2,303,7923,508,027
Sector
Consumer StaplesHealth
52-Week High
$119.61$95.18
52-Week Low
$67.23$72.65
Typical Hold Time
122 Days—
Enterprise Value
$39.97B$45.90B
Dividend Yield
1.48%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Estee Lauder Companies Inc

Estée Lauder (EL) trades at $94.32, up 1.03% today, with a bullish technical signal from moving averages and recent earnings beats. The company reported a net loss of $1.13 billion in 2025 despite a high gross margin of 75.5%, while 2026 forecasts show a return to profitability. Analysts maintain a consensus buy rating with a $103 price target, supported by strategic partnerships in AI and leadership changes aimed at driving growth.

The stock's outlook is cautiously optimistic, with earnings recovery and digital initiatives offering upside, but high debt levels and margin pressures pose risks. Investor sentiment is mixed amid volatile cash flows and competitive headwinds in the beauty sector.

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EL
0% Buy100% Sell
Avg holding period · 122 Days
EW

No sentiment data available yet.

Top news

Latest headlines on both assets

About Estee Lauder Companies Inc

Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Read more on EL →

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →